Manila Bulletin
FDA cancels inspection trip to Russia after Gamaleya submits EUA documents
The FDA has canceled its planned inspection trip to Russia because the Gamaleya Institute has already submitted the necessary documents for the Sputnik V vaccine's emergency use authorization (EUA).
An FDA team was originally scheduled to travel to Russia to inspect the Gamaleya manufacturing facility.
Gamaleya submitted its EUA application after withdrawing a previous bid for a clinical trial in the Philippines.
The Philippines may order 5 to 10 million doses of Sputnik V once it secures EUA approval.
The FDA has already granted EUA for vaccines from Pfizer-BioNTech, AstraZeneca, and Sinovac.
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.
The Food and Drug Administration (FDA) has granted an emergency use authorization (EUA) for Russia's Sputnik V vaccine against COVID-19.
Read more →
The Philippine FDA has granted an emergency use authorization (EUA) for Russia's Sputnik V vaccine, making it the fourth vaccine to receive regulatory approval in the country.
Read more →